Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

In Reply

Archer, David F. MD; Constantine, Ginger D. MD; Simon, James MD; Kushner, Harvey PhD; Mayer, Philip PhD; Bernick, Brian MD; Graham, Shelli PhD; Mirkin, Sebastian MD

doi: 10.1097/GME.0000000000000940
Letters to the Editor
Buy

Clinical Research Center, Department of Obstetrics and Gynecology Eastern Virginia Medical School, Norfolk, VA

EndoRheum Consultants, LLC, Malvern, PA

The George Washington University School of Medicine, Washington, DC

BioMedical Computer Research Institute, Inc, Philadelphia, PA

Independent Consultant, West Chester, PA

TherapeuticsMD, Boca Raton, FL.

TherapeuticsMD, Boca Raton, FL.

TherapeuticsMD, Boca Raton, FL.

Received 20 April, 2017

Accepted 25 April, 2017

Financial disclosure/conflicts of interest: Dr Archer (within the past 3 y) has received research support from Actavis (previously Allergan, Watson Pharmaceuticals, Warner Chilcott), Bayer Healthcare, Endoceutics, Glenmark, Merck (previously Schering Plough, Organon), Radius Health Inc, Shionogi Inc, and TherapeuticsMD; and has served as a consultant to Abbvie (previously Abbott Laboratories), Actavis (previously Allergan, Watson Pharmaceuticals, Warner Chilcott), Agile Therapeutics, Bayer Healthcare, Endoceutics, Exeltis (previously CHEMO), InnovaGyn, Merck (previously Schering Plough, Organon), Pfizer, Radius Health Inc, Sermonix Pharmaceuticals, Shionogi Inc, Teva Women's Healthcare, and TherapeuticsMD. Dr Constantine consults to multiple pharmaceutical companies including but not limited to TherapeuticsMD and has stock options from TherapeuticsMD. Dr Simon has served (within the last year) or is currently serving as a consultant to or on the advisory boards of AbbVie, Allergan, Plc, AMAG Pharmaceuticals Inc, Amgen Inc, Apotex Inc, Ascend Therapeutics, Azure Biotech, JDS Therapeutics, Merck & Co, Millendo Therapeutics, Noven, Novo Nordisk, Nuelle, Perrigo Company, PLC, Radius Health Inc, Regeneron Pharmaceuticals Inc, Roivant Sciences Inc, Sanofi SA, Sebela Pharmaceuticals Inc, Sermonix Pharmaceuticals, Shionogi Inc, Sprout Pharmaceuticals, Symbiotec Pharmalab, TherapeuticsMD, and Valeant Pharmaceuticals; has received (within the last year) or is currently receiving grant/research support from AbbVie, Actavis, PLC, Agile Therapeutics, Bayer Healthcare, GlaxoSmithKline, New England Research Institute, Novo Nordisk, Palatin Technologies, Symbio Research Inc, and TherapeuticsMD; and has also served (within the last year) or is currently serving on the speaker's bureaus of Amgen, Eisai, Merck, Noven Pharmaceuticals, Novo Nordisk, Shionogi Inc, and Valeant Pharmaceuticals. Dr Kushner and Dr Mayer consult to pharmaceutical companies including but not limited to TherapeuticsMD. Dr Bernick is a board member and an employee of TherapeuticsMD with stock/stock options. Dr Graham and Dr Mirkin are employees of TherapeuticsMD with stock/stock options.

© 2017 by The North American Menopause Society.